Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae

Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales

(2020) Marco Falcone et al.   CLINICAL INFECTIOUS DISEASES

Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing Enterobacterales

(2020) Beatriz Dietl et al.   Future Microbiology

Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort

(2020) Juan José Castón et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background

(2020) Lingxiao Sun et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Isolates in a Chinese Tertiary Hospital

(2020) Dan Li et al.   Infection and Drug Resistance

Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis

(2020) Marco Fiore et al.   Antibiotics-Basel

Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

(2019) P. Zhang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically Ventilated Patients

(2019) Vasiliki Tsolaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

(2019) Sarah C J Jorgensen et al.   Open Forum Infectious Diseases

Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae

(2018) Mario Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

OUP accepted manuscript

(2018)   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

(2016) Yi-Yun Liu et al.   LANCET INFECTIOUS DISEASES

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

(2013) George G. Zhanel et al.   DRUGS

Validation study of Charlson Comorbidity Index in predicting mortality in Chinese older adults

(2013) Tuen-Ching Chan et al.   Geriatrics & Gerontology International

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES